Dorsey Wright & Associates Bio N Tech Se Transaction History

Dorsey Wright & Associates

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 27, 2022	SELL	$126.25 - $231.85 $2.92 Million - $5.36 Million	-23,117 Closed	0 $0
Q4 2021 Jan 27, 2022	BUY	$216.64 - $362.52 $89,039 - $148,995	411 Added 1.81%	23,117 $5.96 Million
Q3 2021 Oct 26, 2021	SELL	$205.93 - $447.23 $3.88 Million - $8.42 Million	-18,826 Reduced 45.33%	22,706 $6.2 Million
Q2 2021 Jul 23, 2021	BUY	$113.32 - $241.49 $149,922 - $319,491	1,323 Added 3.29%	41,532 $9.3 Million
Q1 2021 Apr 27, 2021	BUY	$85.73 - $119.5 $3.45 Million - $4.8 Million	40,209 New	40,209 $4.39 Million

357

38.3M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $27.4B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Dorsey Wright & Associates, based on Form 13F filings with the SEC.

Stay updated on Dorsey Wright & Associates with notifications on news.